XML 17 R4.htm IDEA: XBRL DOCUMENT v3.23.4
Consolidated Statements of Operations - USD ($)
 12 Months Ended
Sep. 30, 2023
Sep. 30, 2022
Income Statement [Abstract]    
Revenues
Operating Expenses:    
Research and development 14,819,729 17,655,482
General and administrative 15,295,584 11,754,609
Stock-based compensation – general and administrative 6,616,705 3,905,954
Total Operating Expenses 36,732,018 33,316,045
Operating Loss (36,732,018) (33,316,045)
Other Income:    
Interest income 1,179,417 251,399
Gain on sale of New Jersey net operating losses 3,585,689
Total Other Income 4,765,106 251,399
Loss before Income Taxes (31,966,912) (33,064,646)
Income tax expense 576,000 576,000
Net Loss (32,542,912) (33,640,646)
Deemed dividend on warrant extension 1,151,208
Net Loss Applicable to Common Stockholders $ (33,694,120) $ (33,640,646)
Net Loss Per Share Applicable to Common Stockholders - Basic (in Dollars per share) $ (0.22) $ (0.23)
Weighted Average Common Shares Outstanding    
Basic (in Shares) 151,294,729 146,082,399